WELL Health Forges AI Alliance to Tackle Cardiac Care Delays

WELL Health partners with AliveCor to deploy AI heart monitoring, targeting Canada's 53% surge in cardiology wait times. The move follows record $1.4B revenue and aims to create a new revenue stream.

WELL Health Technologies is addressing critical wait times in Canadian cardiac care through a newly finalized strategic partnership. The company has joined forces with AliveCor to deploy artificial intelligence-powered heart monitoring directly to patients' homes. This collaboration aims to bridge the growing gap in specialist care by merging AI-driven analysis with clinician-led oversight.

Financial Ambitions and Recent Performance

This technological push builds upon a strong financial foundation. For the 2025 fiscal year, WELL Health reported record revenue of US$1.40 billion, marking a 52% year-over-year increase. Adjusted EBITDA also hit a new high of US$203.7 million.

Looking ahead to the full 2026 year, management has established the following targets:
- Revenue: US$1.55 to US$1.65 billion
- Adjusted EBITDA: US$175 to US$185 million
- Strategic Focus: Enhancing free cash flow and optimizing its international portfolio

A Digital Solution for a Systemic Crisis

The initiative is a direct response to severe strain within the national healthcare system. Wait times for elective cardiology consultations have surged by 53% in just one year. Patients now face an average delay of 15.3 weeks to see a specialist. The integrated service is designed to facilitate faster clinical decision-making and potentially reduce unnecessary visits to emergency departments.

From a business perspective, the alliance creates a novel, direct revenue stream. WELL Health will receive compensation for each cardiological review conducted through the shared platform, thereby expanding its clinical services income.

How the Integrated Service Operates

At the core of the agreement is the incorporation of WELL Health's network of cardiologists into AliveCor's Kardia platform. Users who record an electrocardiogram (ECG) using a personal device can subsequently request a professional clinical assessment.

The process employs a two-stage model:
1. AliveCor's proprietary AI algorithms provide an initial analysis of the cardiac data.
2. A cardiologist from the WELL Health network then reviews the AI's findings to either confirm or refine them.

This structure delivers a comprehensive medical evaluation to the patient, complete with written guidance for next steps, all without requiring an in-person clinic visit.

The integration of AI-assisted services is a key component of WELL Health's strategy to boost practitioner efficiency and modernize outpatient care. Investors are now anticipating the next quarterly report, scheduled for mid-May 2026, which will offer early indicators of how these new digital offerings are contributing to growth.